Alpha-fetoprotein-derived antiestrotrophic octapeptide

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1501, Issue 1, 2000, Pages 33-43

  Mesfin, Fassil B ^a   Bennett, James A ^b   Jacobson, Herbert I ^a   Zhu, Shuji ^a   Andersen, Thomas T ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

^b Albany Medical School   (United States)

Author keywords

Alpha fetoprotein; Breast cancer; Synthetic octapeptide

Indexed keywords

ALPHA FETOPROTEIN; ANTIESTROGEN; PEPTIDE DERIVATIVE;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN STRUCTURE;

ALPHA-FETOPROTEINS; AMINO ACID SEQUENCE; ANIMALS; BODY WEIGHT; BREAST NEOPLASMS; CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DESIGN; ESTRADIOL; ESTROGEN RECEPTOR MODULATORS; FEMALE; HUMANS; MICE; MOLECULAR SEQUENCE DATA; OLIGOPEPTIDES; ORGAN SIZE; PEPTIDES; PROTEIN STRUCTURE, SECONDARY; UTERUS;

ANIMALIA;

EID: 0034655853     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(00)00008-9     Document Type: Article

References (29)

1. Crandall B.F. Alpha-fetoprotein: a review. Crit. Rev. Clin. Lab. Sci. 15:1981;127-185.
2. Ruoslahti E., Terry W.D. Alpha-fetoprotein and serum albumin show sequence homology. Nature. 260:1976;804-805.
3. Morinaga T., Sakai M., Wegmann T.G., Tamaoki T. Primary structures of human alpha-fetoprotein and its mRNA. Proc. Natl. Acad. Sci. USA. 80:1983;4604-4608.
4. Bennett J.A., Zhu S., Mirarchi A.P., Kellom T.A., Jacobson H.I. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts. Clin. Cancer Res. 4:1998;2877-2884.
5. Bennett J.A., Zhu S., Mirarchi A.P., Jacobson H.I. Human hepatoma derived alpha-fetoprotein inhibits hormone dependent human breast and prostate cancer xenograft growth. Proc. Am. Assoc. Cancer Res. 39:1998;387.
6. Bennett J.A., Semeniuk D.J., Jacobson H.I., Murgita R.A. Similarity between natural and recombinant human alpha-fetoprotein as inhibitors of estrogen-dependent breast cancer growth. Breast Cancer Res. Treat. 45:1997;169-179.
7. Allen S.H.G., Bennett J.A., Mizejewski G.J., Andersen T.T., Ferraris S., Jacobson H.I. Purification of alpha-fetoprotein from human cord serum with demonstration of its antiestrogenic activity. Biochim. Biophys. Acta. 1202:1993;135-142.
8. Bennett J.A., Pilon V.A., Briggs D.R., McKneally M.F. Evaluation of cyclosporine-treated mice as hosts for growing and testing the chemosensitivity of first-transplant-generation human tumor xenografts implanted under the kidney capsule. J. Natl. Cancer Inst. 75:1985;925-936.
9. Bennett J.A., Pilon V.A., MacDowell R.T. Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice. Cancer Res. 45:1985;4963-4969.
10. Festin S.M., Bennett J.A., Fletcher P., Jacobson H.I., Andersen T.T. Anti-estrogenic activity of secreted and non-secreted forms of domain III of human alpha-fetoprotein produced in a baculovirus system. Proc. Am. Assoc. Cancer Res. 38:1997;572.
11. Festin S.M., Bennett J.A., Fletcher P.W., Jacobson H.I., Andersen T.T. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule. Biochim. Biophys. Acta. 1427:1999;307-314.
12. Jacobson H.I., Bennett J.A., Mizejewski G.J. Inhibition of estrogen-dependent breast cancer growth by a reaction product of alpha-fetoprotein and estradiol. Cancer Res. 50:1990;415-420.
13. Jacobson H.I., Marotta D., Mizejewski G.J., Bennett J.A., Andersen T.T. Estradiol-induced changes in spectra and biological properties of alpha-fetoprotein. Tumor Biol. 11:1990;104.
14. Mizejewski G.J., Dias J.A., Hauser C.R., Henrikson K.P., Gierthy J. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment. Mol. Cell. Endocrinol. 118:1996;15-23.
15. Rost B., Sander C. Improved prediction of protein secondary structure by use of sequence profiles and neural networks. Proc. Natl. Acad. Sci. USA. 90:1993;7558-7562.
16. Brooks B.R., Bruccoleri R.E., Olafson B.D., States D.J., Swaminathan S., Karplus M. CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. J. Comput. Chem. 4:1983;187-217.
17. Strydom D.J., Cohen S.A. Comparison of amino acid analyses by phenylisothiocyanate and 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate precolumn derivatization. Anal. Biochem. 222:1994;19-28.
18. Cohen S.A., Michaud D.P. Synthesis of a fluorescent derivatizing reagent, 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate, and its application for the analysis of hydrolysate amino acids via high-performance liquid chromatography. Anal. Biochem. 211:1993;279-287.
19. Mizejewski G.J., Vonnegut M., Jacobson H.I. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens. Proc. Natl. Acad. Sci. USA. 80:1983;2733-2737.
20. Wu J.T., Knight J.A. In-vitro stability of human alpha-fetoprotein. Clin. Chem. 31:1985;1692-1697.
21. Lai M.C., Topp E.M. Solid-state chemical stability of proteins and peptides. J. Pharmacol. Sci. 88:1999;489-500.
22. Reubsaet J.L., Beijnen J.H., Bult A., van Maanen R.J., Marchal J.A., Underberg W.J. Analytical techniques used to study the degradation of proteins and peptides: physical instability. J. Pharmacol. Biomed. Anal. 17:1998;979-984.
23. Wingo P.A., Ory H.W., Layde P.M., Lee N.C. The evaluation of the data collection process for a multicenter, population-based, case-control design. Am. J. Epidemiol. 128:1988;206-217.
24. Jacobson H.I., Thompson W.D., Janerich D.T. Multiple births and maternal risk of breast cancer. Am. J. Epidemiol. 129:1989;865-873.
25. Janerich D.T., Mayne S.T., Thompson W.D., Stark A.D., Fitzgerald E.F., Jacobson H.I. Familial clustering of neural tube defects and gastric cancer. Int. J. Epidemiol. 19:1990;516-521.
26. Ekbom A., Trichopoulos D., Adami H.O., Hsieh C.C., Lan S.J. Familial clustering of neural tube defects and gastric cancer. Lancet. 340:1992;1015-1018.
27. Richardson B.E., Hulka B.S., David-Peck J.L., Hughes C.L., Van den Berg B.J., Christianson R.E., Calvin J.A. Levels of maternal serum alpha-fetoprotein in pregnant women and subsequent breast cancer risk. Am. J. Epidemiol. 148:1998;719-727.
28. Grubbs C.J., Hill D.L., McDonough K.C., Peckham J.C. N-Nitroso-N-methylurea induced mammary carcinogenesis: effect of pregnancy on preneoplastic cells. J. Natl. Cancer Inst. 71:1983;625-628.
29. Sonnenschein C., Ucci A.A., Soto A.M. Growth inhibition of estrogen sensitive rat mamary tumors. Effect of an alpha-fetoprotein secreting hepatoma. J. Natl. Cancer Inst. 64:1980;1147-1152.